| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_271480a5c97eec04daf2399af96b3f6f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2007-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3fa42108c8acb997e98009ecf049340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fd36ac4aa47379907ec31765bccbd5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8700b4fdde6965b59ca3aa525a6a124 |
| publicationDate |
2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-577390-A |
| titleOfInvention |
Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction |
| abstract |
Provided is the use of testosterone and a 5-HT1A agonist in the preparation of a medicament for the treatment of sexual dysfunction, wherein said medicament is used on demand, wherein said 5-HT1A agonist is released essentially one hour before and said testosterone essentially 3.5-5.5 hours prior to sexual activity so that the peak effects of the 5-HT1A agonist and testosterone partly overlap, wherein said testosterone is provided as a short-lasting peak, and wherein the amount of testosterone is at most 2.5 mg. |
| priorityDate |
2006-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |